Iris prolapse is a condition in which the iris, the colored part of the eye, bulges forward and causes a visible “prolapse”. This condition can be caused by eye trauma or surgery, though it is most common among those born with certain congenital ocular anomalies. In this blog post, we will discuss what causes iris prolapse, how to diagnose it and the various approaches to treating it. By arming yourself with this knowledge you will be able to better help your patients manage their symptoms and live life more comfortably.
The iris is the colored part of the eye that surrounds the pupil. The pupil is the black center of the eye, which gets bigger or smaller to let in more or less light. The iris controls how much light enters the eye. Iris prolapse happens when part of the iris bulges forward into the pupil. This can happen because of an injury, trauma, surgery, or other condition that weakens the muscles or tissues around the eye. Iris prolapse can also happen on its own, without any known cause.
-Eye pain
-Sensitivity to light
-Blurry vision
-The appearance of a “halo” around lights
-The feeling that there is something in your eye
The iris is the colored part of the eye that controls how much light enters the eye. It is made up of two layers: the front layer, called the epithelium, and the back layer, called the stroma. The stroma contains collagen fibers and pigmented cells that give the iris its color. The space between the epithelium and stroma is filled with a clear gel-like substance called the aqueous humor. The iris prolapse can be caused by different things. One cause can be due to trauma or injury to the eye which causes the tissues to become weak or stretched. This can happen from a blow to the head or face, an accident, or even surgery on the eye. Another cause of iris prolapse can be due to certain diseases such as glaucoma, diabetes, or other conditions that increase pressure inside the eye. This extra pressure can cause the iris tissue to become weak and eventually lead to prolapse.
Most cases of iris prolapse can be treated with surgery to reposition the iris. In some cases, a contact lens may be used to protect the exposed surface of the eye. If there is significant damage to the eye, a corneal transplant may be necessary. Treatment usually involves operating to put the iris back in place and repairing any damage to the eye.
Iris prolapse is a common eye disorder that affects the eyes of many people. It is important for medical professionals to be familiar with the causes, diagnosis and treatment options available so they can properly advise and treat patients. By knowing how iris prolapse presents itself and understanding the risks associated with surgery, medical personnel can better address any concerns a patient may have in relation to this condition. With proper care, it's possible for individuals affected by iris prolapse to achieve satisfactory outcomes both medically and aesthetically.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation